"What" Series

What is Drug Interaction?

3 April 2024
2 min read

A drug interaction occurs when two or more drugs interact in the body, affecting the efficacy or safety of one or both medications. These interactions can be beneficial, leading to improved therapeutic outcomes, or they can be harmful, resulting in reduced effectiveness or increased risk of side effects.

Key aspects of drug interactions include:

·Pharmacokinetic Interactions: These involve changes in the way a drug is absorbed, distributed, metabolized, or excreted by the body. For example, one drug may inhibit or induce the enzymes responsible for metabolizing another drug, leading to altered drug levels in the body.

·Pharmacodynamic Interactions: These occur when drugs have additive, synergistic, or antagonistic effects on the same physiological pathway or outcome. Additive effects can occur when two drugs with similar actions are used together, resulting in a combined effect that may be more than the sum of their individual effects.

·Drug-Drug Interactions (DDIs): These are interactions between prescription drugs, over-the-counter medications, or supplements that can alter the effects of one or both substances.

·Management: To manage drug interactions, healthcare providers may adjust dosages, change the timing of medication administration, or recommend avoiding certain combinations of drugs.

·Importance: Understanding and managing drug interactions is crucial to ensure patient safety and the effectiveness of treatment. Patients should inform their healthcare providers about all medications and supplements they are taking to help identify and mitigate potential interactions.

·Prediction and Assessment: Some drug interactions are well-known and can be predicted based on the pharmacological properties of the drugs involved. Others may be less predictable and require monitoring and clinical assessment.

·Reporting: Healthcare professionals and patients are encouraged to report suspected drug interactions to regulatory authorities to contribute to the understanding and management of these interactions.

Drug interactions highlight the complexity of polypharmacy (the use of multiple medications by a single patient) and underscore the need for careful medication management, particularly in patients with multiple health conditions who may be on several medications concurrently.

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

U.S. Review of Datopotamab Deruxtecan for Pre-Treated HR+/HER2- Breast Cancers
Latest Hotspot
3 min read
U.S. Review of Datopotamab Deruxtecan for Pre-Treated HR+/HER2- Breast Cancers
3 April 2024
The U.S. authorities have endorsed the review of a licensing request for Datopotamab Deruxtecan.
Read →
IASO Bio Reveals Chinese Regulatory Green Light for Advanced MM Therapy with Equecabtagene Autoleucel
Latest Hotspot
3 min read
IASO Bio Reveals Chinese Regulatory Green Light for Advanced MM Therapy with Equecabtagene Autoleucel
3 April 2024
IASO Bio has disclosed official authorization from the China National Medical Products Administration for the clinical trial application of Equecabtagene Autoleucel.
Read →
Bristol Myers Squibb Reports KRYSTAL-12 Study Success with KRAZATI (Adagrasib) Halting Advanced KRASG12C-Mutant NSCLC Progression
Latest Hotspot
3 min read
Bristol Myers Squibb Reports KRYSTAL-12 Study Success with KRAZATI (Adagrasib) Halting Advanced KRASG12C-Mutant NSCLC Progression
3 April 2024
Bristol Myers Squibb Reveals Key Outcomes from KRYSTAL-12 Study on KRAZATI (adagrasib) Demonstrating Main Goal of Halting Disease Progress in Advanced KRASG12C-Altered Non-Small Cell Lung Cancer.
Read →
EU Approves Merck's KEYTRUDA® for Initial and Adjuvant Treatment in High-Risk NSCLC
Latest Hotspot
3 min read
EU Approves Merck's KEYTRUDA® for Initial and Adjuvant Treatment in High-Risk NSCLC
3 April 2024
The EU Commission has approved the use of Merck's drug KEYTRUDA® (pembrolizumab) in combination with chemotherapy as a first treatment.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.